 Cytostatic effects suramin prostate cancer cells primary tumors Suramin undergoing clinical trials chemotherapeutic agent prostate cancer effects suramin cultured human epithelial cells normal benign hyperplastic malignant prostate tissues serum-free medium suramin clonal growth prostate cells half-maximal dose micrograms/ml Growth inhibition suramin reversible hours exposure conjunction suramin cellular phenotype regard expression keratins prostate-specific antigens suramin antagonist growth factor-mediated mitogenesis ten-fold excesses growth factors cytostatic activity suramin comparison activities possible chemotherapeutic agents suramin suboptimal inhibitory effects reversible cellular phenotype